Prospective serum metabolomic profile of prostate cancer in the atbc study. June 27, 2017 - september 26, 2017.
Ended Awarded Last action
- Contract number
- HHSN26100002
- Awardee
-
Metabolon, Inc. UEI SBY5A7EK9PU3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $280,500
Award facts
- Opportunity
-
- N02CP7100272 Solicitation number
- Metabolomic Profiling for Molecular Epidemiology Studies Award Notice · Posted Oct 31, 2016
- Contract value 100% obligated
- $280,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27713, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $280,500 |
About this award
This firm fixed price delivery order, valued at $280,500.00, was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Metabolon, Inc. for the "PROSPECTIVE SERUM METABOLOMIC PROFILE OF PROSTATE CANCER IN THE ATBC STUDY" with a period of performance from June 27, 2017 to September 26, 2017. Metabolon, a self-certified small disadvantaged business, is a leading provider of metabolomics solutions and has served as a prime contractor on numerous federal contracts, providing specialized metabolomics analysis services to agencies like the Department of Veterans Affairs, National Institutes of Health, and Department of Defense. This delivery order was not set aside. Metabolon will leverage its DiscoveryHD4 metabolomics platform and statistical analysis expertise to characterize metabolic signatures associated with prostate cancer, with the goal of developing more precise diagnostics and clinical decision-making tools.
Quick answers
Who was awarded contract HHSN26100002?
HHSN26100002 was awarded to Metabolon, Inc. by National Cancer Institute (National Institutes of Health) on June 27, 2017.
How much is contract HHSN26100002 worth?
The government has obligated $280,500 on HHSN26100002.
Is contract HHSN26100002 an order under another contract?
Yes. HHSN26100002 is a delivery order under HHSN261201700009I, an indefinite delivery contract.
Was contract HHSN26100002 competed?
The extent of competition for HHSN26100002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award